The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Patients & Providers Push for Step Therapy, Workforce Changes

Rheumatology Patients & Providers Push for Step Therapy, Workforce Changes

September 20, 2019 • By Kelly Tyrrell

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Attendees met with 117 legislators during the event.

Editor’s note: Read a first-person account of the event from Angus Worthing, MD, FACR, FACP, below.

You Might Also Like
  • Advocates for Arthritis Will Target Step Therapy, Workforce Shortage
  • Texas Rheumatologists Push for Passage of Step Therapy Reforms
  • Step Therapy and Biosimilar Substitution Top the Priority List for the Rheumatology Association of Iowa
Explore This Issue
November 2019
Also By This Author
  • Get to Know the ARP’s Power Couple

On Sept. 9 and 10, 2019, 112 rheumatology advocates visited 117 of the nation’s top lawmakers and their staffs on Capitol Hill during the ACR’s annual Advocates for Arthritis event, bringing rheumatology professionals and patients together to make their voices heard in the halls of Congress. The meetings this year focused on workforce shortages in rheumatology and on limiting the effects of step therapy, whereby insurers may not approve a doctor-prescribed therapy until the patient has tried a drug preferred by the insurance company, even if the doctor believes the insurer-preferred treatment will not be effective for the patient.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Twenty-two rheumatology fellows also took part in the ACR’s Advocacy 101 program. The course is designed to educate trainees about legislative and regulatory healthcare policies impacting rheumatology and about the challenges of the changing healthcare system that they will face in their careers and practices. The program also engages fellows in health policy and advocacy endeavors.

“I think the issues struck a chord for all of our advocates,” says Angus Worthing, MD, FACR, FACP, a D.C.-based rheumatologist and chair of the ACR’s Government Affairs Committee (GAC). “We are essentially trying to reduce wait times for people to get into a doctor’s office and to get on the medications they need by bolstering the workforce and working on step therapy.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Advocates also pressed legislators on drug costs. Dr. Worthing says, “Congress and the Trump administration are facing well-deserved pressure from the American public to reduce drug prices and the cost to patients, so the timing was great for us to tell them what the rheumatology community cares about.”

“Meeting with representatives is a great way to exercise our First Amendment rights and feel like we are doing something,” says Ethan Craig, MD, MHS, a rheumatologist at Penn Medicine and GAC member.

Congressional Education
Laura Ballenger, MD, a third-year pediatric rheumatology fellow at Nationwide Children’s Hospital in Columbus, Ohio, returned to Advocates for Arthritis after taking part in Advocacy 101 last year.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“The biggest thing that brought me back is advocacy is really based on educating people and that’s one part of the medical world I really enjoy,” Dr. Ballenger says. “I met with some people again who I met with last year, and it’s exciting to continue the conversation.”

Pages: 1 2 3 4 | Single Page

Filed Under: Legislation & Advocacy Tagged With: Advocacy 101, Advocates for Arthritis, RheumPACIssue: November 2019

You Might Also Like:
  • Advocates for Arthritis Will Target Step Therapy, Workforce Shortage
  • Texas Rheumatologists Push for Passage of Step Therapy Reforms
  • Step Therapy and Biosimilar Substitution Top the Priority List for the Rheumatology Association of Iowa
  • The ACR & ARP Fight Step Therapy on Capitol Hill

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)